Vaginal danazol for women with rectovaginal endometriosis and pain symptoms persisting after insertion of a levonorgestrel‐releasing intrauterine device
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Objective: To evaluate the effectiveness of treatment with vaginal danazol in improving the pain symptoms caused by rectovaginal endometriosis that persist after insertion of a levonorgestrel‐releasing intrauterine device (LNG‐IUD). Methods: This pilot observational study included 15 women with rectovaginal endometriosis and pain symptoms persisting after LNG‐IUD insertion. Vaginal danazol (100 mg per day) was self‐administered for 6 months. The intensity of pain symptoms and the volume of rectovaginal endometriotic nodules were evaluated. Results: Twelve women were satisfied or very satisfied with the treatment. After treatment with vaginal danazol for 3 months, there was a significant decrease in the intensity of pain symptoms compared with their intensity before the administration of danazol. The intensity of pain symptoms decreased further at 6‐month follow‐up. The volume of the rectovaginal nodules decreased after treatment with vaginal danazol for 6 months (1.7 ± 0.8 cm 3) compared with the baseline volume (2.3 ± 0.9 cm 3; P < 0.001). Adverse effects of the treatment were minimal and well tolerated. Conclusion: Although a placebo effect cannot be excluded, the results indicate that vaginal danazol decreases the severity of endometriosis‐related pain symptoms after LNG‐IUD insertion.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Petta, C. A., Ferriani, R. A., Abrao, M. S., Hassan, D., Rosa e Silva, J. C., Podgaec, S., & Bahamondes, L. (2005) · Human Reproduction · doi:10.1093/humrep/deh869 · Cited by 363 · cited 1×
“The insertion of a levonorgestrel-releasing intrauterine device (LNG-IUD) significantly improves the pain associated with endometriosis [1–6]; in addition, this procedure decreases serum CA-125 levels [7], American Society for Reproductive Medicine (ASRM) stage of endometriosis [2], and the risk of recurrence of dysme…”
BackgroundUse of a levonorgestrel-releasing intrauterine device in the treatment of rectovaginal endometriosis
Fedele, L., Bianchi, S., Zanconato, G., Portuese, A., & Raffaelli, R. (2001) · Fertility and Sterility · doi:10.1016/s0015-0282(00)01759-3 · Cited by 290
Dosage aspects of danazol therapy in endometriosis: Short-term and long-term effectiveness
Biberoglu, K. O., & Behrman, S. J. (1981) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(81)90478-6 · Cited by 267
Vercellini, P., Frontino, G., De Giorgi, O., Aimi, G., Zaina, B., & Crosignani, P. G. (2003) · Fertility and Sterility · doi:10.1016/s0015-0282(03)00608-3 · Cited by 263
Danazol for pelvic pain associated with endometriosis
Farquhar, C., Prentice, A., Singla, A. A., & Selak, V. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000068.pub2 · Cited by 210 · cited 1×
“Treatment with danazol reduces the intensity of symptoms caused by endometriosis, but its long-term use is limited by the occurrence of androgenic adverse effects [10,11].”
BackgroundLockhat, F. B. (2004) · Human Reproduction · doi:10.1093/humrep/deh004 · Cited by 135
Efficacy of vaginal danazol treatment in women with recurrent deeply infiltrating endometriosis
Razzi, S., Luisi, S., Calonaci, F., Altomare, A., Bocchi, C., & Petraglia, F. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.12.077 · Cited by 100 · cited 2×
“It has previously been shown that vaginal danazol does not result in significant changes in metabolic or thrombophilic parameters [13,15].”
BackgroundIgarashi, M., Iizuka, M., Abe, Y., & Ibuki, Y. (1998) · Human Reproduction · doi:10.1093/humrep/13.7.1952 · Cited by 73
de Sá Rosa e Silva, A. C. J., Rosa e Silva, J. C., Nogueira, A. A., Petta, C. A., Abrão, M. S., & Ferriani, R. A. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.02.082 · Cited by 46
Cited by
Treatment of pelvic pain associated with endometriosis: a committee opinion
(2014) · Fertility and Sterility · doi:10.1016/j.fertnstert.2014.02.012 · Cited by 397
Role of medical therapy in the management of deep rectovaginal endometriosis
Vercellini, P., Buggio, L., & Somigliana, E. (2017) · Fertility and Sterility · doi:10.1016/j.fertnstert.2017.08.038 · Cited by 62
Szubert, M., Suzin, J., Duechler, M., Szulawska, A., Czyz, M., & Kowalczyk-Amico, K. (2014) · Reproduction, Fertility and Development · doi:10.1071/rd12258 · Cited by 36
Vaginally Administered Danazol: An Overlooked Option in the Treatment of Rectovaginal Endometriosis?
Godin, R., & Marcoux, V. (2015) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(16)30075-5 · Cited by 30
Vaginal danazol for the treatment of endometriosis-related pelvic pain
Bhattacharya, S. M., Tolasaria, A., & Khan, B. (2011) · International Journal of Gynecology & Obstetrics · doi:10.1016/j.ijgo.2011.06.021 · Cited by 10
Metadata
- Authors
- Ferrero, S., Tramalloni, D., Venturini, P. L., & Remorgida, V.
- Venue
- International Journal of Gynecology & Obstetrics
- Publisher
- Wiley
- Published
- 2011-02-18
- Volume
- 113
- Issue
- 2
- Pages
- 116-119
- ISSN
- 0020-6695 (ISSN-L)
- 0020-7292
- 1879-3479
- OpenAlex
- W2009231867
- Cited by
- 32
- References
- 9
- FWCI
- 1.93
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Vaginal danazol for women with rectovaginal endometriosis and pain symptoms persisting after insertion of a levonorgestrel‐releasing intrauterine device. https://app.cochat.ai/papers/10.1016/j.ijgo.2010.11.015
- The paper
- Ferrero, S., Tramalloni, D., Venturini, P. L., & Remorgida, V. (2011). Vaginal danazol for women with rectovaginal endometriosis and pain symptoms persisting after insertion of a levonorgestrel‐releasing intrauterine device. International Journal of Gynecology & Obstetrics. https://doi.org/10.1016/j.ijgo.2010.11.015
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.